The antitumor effects of nitroxoline in chemoresistant BC cells were based on the downregulation of STAT3 signaling followed by downregulation of the anti-apoptotic proteins Bcl-xl, Mcl-1 and Survivin, among others (60). Here, BIRC5 is linked to breast cancer.